LXCHEM.NS
Laxmi Organic Industries Limited [LXCHEM.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
LXCHEM.NS Stock Summary
Top 10 Correlated ETFs
LXCHEM.NS
Top 10 Correlated Stocks
LXCHEM.NS
In the News
LXCHEM.NS Financial details
Company Rating
Neutral
Market Cap
71.48B
Income
1.01B
Revenue
28.13B
Book val./share
-
Cash/share
-
Dividend
0.5
Dividend %
0.18%
Employees
874
Optionable
No
Shortable
Yes
Earnings
29 May 2024
P/E
73.76
Forward P/E
-
PEG
-11.98
P/S
2.82
P/B
5.09
P/C
-
P/FCF
684.78
Quick Ratio
1.09
Current Ratio
1.64
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
3.75
EPS next Y
-
EPS next Q
-
EPS this Y
-51.84%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
10.21%
Revenue last 5Y
12.39%
Revenue Q/Q
6.44%
EPS Q/Q
147.5%
-
-
-
-
SMA20
5.42%
SMA50
-5.24%
SMA100
-7.66%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
14%
ROC
0.1%
Gross Margin
33%
Oper. Margin
6%
Profit Margin
4%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
221.8-320.95
52W High
-22.17%
52W Low
+12.69%
RSI
53
Rel Volume
0.46
Avg Volume
1.04M
Volume
475.61K
Perf Week
-2.64%
Perf Month
-2.56%
Perf Quarter
-5.41%
Perf Half Y
-13.25%
-
-
-
-
Beta
0.101
-
-
Volatility
3.64%, 10.76%
Prev Close
-0.38%
Price
249.05
Change
1.2%
LXCHEM.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 62.25 | 62.4 | 77.5 | 116.8 | 105.54 | |
| Net income per share | 2.89 | 2.86 | 5.59 | 9.76 | 4.7 | |
| Operating cash flow per share | 7.49 | 8.01 | 5.4 | 1.73 | 7.51 | |
| Free cash flow per share | 3.6 | 4.86 | -0.39 | -9.23 | -10.45 | |
| Cash per share | 1.5 | 0.64 | 22.38 | 5.92 | 8.39 | |
| Book value per share | 17.96 | 17.45 | 45.56 | 49.33 | 53.28 | |
| Tangible book value per share | 17.63 | 17.15 | 45.24 | 49.17 | 53.28 | |
| Share holders equity per share | 17.96 | 17.45 | 45.56 | 49.33 | 53.28 | |
| Interest debt per share | 8.16 | 7.44 | 11.02 | 5.76 | 15.74 | |
| Market cap | 41.19B | 40.24B | 39.63B | 105.31B | 59.02B | |
| Enterprise value | 43B | 41.7B | 41.67B | 106.37B | 62.27B | |
| P/E ratio | 56.9 | 57.41 | 31.19 | 40.92 | 47.38 | |
| Price to sales ratio | 2.64 | 2.64 | 2.25 | 3.42 | 2.11 | |
| POCF ratio | 21.95 | 20.53 | 32.34 | 230.53 | 29.65 | |
| PFCF ratio | 45.69 | 33.84 | -444.54 | -43.26 | -21.32 | |
| P/B Ratio | 9.16 | 9.43 | 3.83 | 8.1 | 4.18 | |
| PTB ratio | 9.16 | 9.43 | 3.83 | 8.1 | 4.18 | |
| EV to sales | 2.76 | 2.73 | 2.37 | 3.45 | 2.23 | |
| Enterprise value over EBITDA | 27.35 | 35.78 | 18.94 | 28.09 | 24.27 | |
| EV to operating cash flow | 22.91 | 21.27 | 34.01 | 232.85 | 31.28 | |
| EV to free cash flow | 47.69 | 35.06 | -467.52 | -43.69 | -22.49 | |
| Earnings yield | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | |
| Free cash flow yield | 0.02 | 0.03 | 0 | -0.02 | -0.05 | |
| Debt to equity | 0.42 | 0.4 | 0.23 | 0.11 | 0.29 | |
| Debt to assets | 0.19 | 0.16 | 0.13 | 0.06 | 0.17 | |
| Net debt to EBITDA | 1.15 | 1.25 | 0.93 | 0.28 | 1.27 | |
| Current ratio | 1.36 | 1.22 | 1.7 | 1.58 | 1.47 | |
| Interest coverage | 7.45 | 5.52 | 11.83 | 25.03 | 16.12 | |
| Income quality | 1.92 | 3.55 | 0.77 | 0.14 | 1.15 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0.02 | 0.02 | 0.06 | 0.05 | 0.15 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.52 | -0.39 | -1.07 | -6.33 | -2.39 | |
| Capex to revenue | -0.06 | -0.05 | -0.07 | -0.09 | -0.17 | |
| Capex to depreciation | -2.21 | -1.58 | -2.83 | -5.87 | -6.57 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0.01 | 0 | |
| Graham number | 34.17 | 33.53 | 75.73 | 104.08 | 75.07 | |
| ROIC | 0.14 | 0.1 | 0.11 | 0.18 | 0.07 | |
| Return on tangible assets | 0.07 | 0.07 | 0.07 | 0.11 | 0.05 | |
| Graham Net | -5.21 | -8.17 | 11.13 | 3.15 | -7.65 | |
| Working capital | 1.65B | 1.18B | 5.38B | 5.41B | 3.87B | |
| Tangible asset value | 4.42B | 4.2B | 10.27B | 12.96B | 14.12B | |
| Net current asset value | 605.6M | 35.97M | 5.03B | 5.06B | 2.17B | |
| Invested capital | 0.42 | 0.4 | 0.23 | 0.11 | 0.29 | |
| Average receivables | 4.02B | 4.42B | 5.31B | 7.68B | 7.56B | |
| Average payables | 2.65B | 3.64B | 4.43B | 5.93B | 5.89B | |
| Average inventory | 1.58B | 1.61B | 1.78B | 2.88B | 3.34B | |
| Days sales outstanding | 96.97 | 112.12 | 123.09 | 111.69 | 74.42 | |
| Days payables outstanding | 102.83 | 133.25 | 142.56 | 120.6 | 91.75 | |
| Days of inventory on hand | 55.64 | 49.17 | 61.02 | 63.31 | 57.88 | |
| Receivables turnover | 3.76 | 3.26 | 2.97 | 3.27 | 4.9 | |
| Payables turnover | 3.55 | 2.74 | 2.56 | 3.03 | 3.98 | |
| Inventory turnover | 6.56 | 7.42 | 5.98 | 5.77 | 6.31 | |
| ROE | 0.16 | 0.16 | 0.12 | 0.2 | 0.09 | |
| Capex per share | -3.89 | -3.15 | -5.79 | -10.97 | -17.96 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 24.69 | 27.65 | 27.62 | 24.56 | 25.28 | |
| Net income per share | 1.03 | 0.92 | 1.44 | 0.4 | 0.99 | |
| Operating cash flow per share | 1.42 | 0.43 | 1.58 | 2.07 | 2 | |
| Free cash flow per share | 1.42 | 0.43 | 1.58 | 2.07 | 2 | |
| Cash per share | 0 | 8.38 | 0 | 5.91 | 0 | |
| Book value per share | 0 | 53.24 | 0 | 54.92 | 0 | |
| Tangible book value per share | 0 | 53.25 | 0 | 54.93 | 0 | |
| Share holders equity per share | 0 | 53.24 | 0 | 54.92 | 0 | |
| Interest debt per share | 0.22 | 15.25 | 0.17 | 6.39 | 0.02 | |
| Market cap | 78.73B | 59.07B | 69.02B | 74.04B | 80.18B | |
| Enterprise value | 78.73B | 62.32B | 69.02B | 75.38B | 80.18B | |
| P/E ratio | 72.29 | 60.73 | 45.02 | 172.79 | 73.72 | |
| Price to sales ratio | 12.03 | 8.06 | 9.41 | 11.35 | 11.55 | |
| POCF ratio | 209.48 | 517.37 | 164.66 | 134.38 | 145.62 | |
| PFCF ratio | 209.48 | 517.37 | 164.66 | 134.38 | 145.62 | |
| P/B Ratio | 0 | 4.18 | 0 | 5.08 | 0 | |
| PTB ratio | 0 | 4.18 | 0 | 5.08 | 0 | |
| EV to sales | 12.03 | 8.5 | 9.41 | 11.56 | 11.55 | |
| Enterprise value over EBITDA | 135.65 | 96.55 | 84.91 | 159.91 | 139.2 | |
| EV to operating cash flow | 209.48 | 545.81 | 164.66 | 136.81 | 145.62 | |
| EV to free cash flow | 209.48 | 545.81 | 164.66 | 136.81 | 145.62 | |
| Earnings yield | 0 | 0 | 0.01 | 0 | 0 | |
| Free cash flow yield | 0 | 0 | 0.01 | 0.01 | 0.01 | |
| Debt to equity | 0 | 0.29 | 0 | 0.11 | 0 | |
| Debt to assets | 0 | 0.17 | 0 | 0.08 | 0 | |
| Net debt to EBITDA | 0 | 5.03 | 0 | 2.84 | 0 | |
| Current ratio | 0 | 1.47 | 0 | 1.64 | 0 | |
| Interest coverage | 6.88 | -33.6 | 12.26 | 9.5 | 57.83 | |
| Income quality | 1.38 | 0.47 | 1.09 | 5.14 | 2.03 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0.21 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0.02 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0.02 | 0 | 0 | 0 | |
| Graham number | 0 | 33.14 | 0 | 22.33 | 0 | |
| ROIC | 0 | 0.01 | 0 | 0.01 | 0 | |
| Return on tangible assets | 0 | 0.01 | 0 | 0 | 0 | |
| Graham Net | 0 | -7.65 | 0 | -3.98 | 0 | |
| Working capital | 1.45B | 3.87B | 1.09B | 3.63B | 0 | |
| Tangible asset value | 0 | 14.12B | 0 | 14.59B | 0 | |
| Net current asset value | 1.45B | 2.17B | 1.09B | 2.15B | 0 | |
| Invested capital | 0 | 0.29 | 0 | 0.11 | 0 | |
| Average receivables | 2.3B | 2.85B | 2.85B | 2.32B | 2.32B | |
| Average payables | 2.26B | 2.33B | 2.33B | 2.26B | 2.26B | |
| Average inventory | 1.75B | 1.47B | 1.47B | 1.06B | 1.06B | |
| Days sales outstanding | 0 | 70 | 0 | 64.06 | 0 | |
| Days payables outstanding | 0 | 86 | 0 | 88.18 | 0 | |
| Days of inventory on hand | 0 | 54.26 | 0 | 41.33 | 0 | |
| Receivables turnover | 0 | 1.29 | 0 | 1.41 | 0 | |
| Payables turnover | 0 | 1.05 | 0 | 1.02 | 0 | |
| Inventory turnover | 0 | 1.66 | 0 | 2.18 | 0 | |
| ROE | 0 | 0.02 | 0 | 0.01 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
LXCHEM.NS Frequently Asked Questions
What is Laxmi Organic Industries Limited stock symbol ?
Laxmi Organic Industries Limited is a IN stock and trading under the symbol LXCHEM.NS
What is Laxmi Organic Industries Limited stock quote today ?
Laxmi Organic Industries Limited stock price is $249.05 today.
Is Laxmi Organic Industries Limited stock public?
Yes, Laxmi Organic Industries Limited is a publicly traded company.
Something similar
Company Profile
- Volume Average 1.04M
- Market Capitalization 71.48B
- Employee 874
- CEO Dr. Rajan Venkatesh
- Headquarters Mumbai,IN
- IPO Date 2021-03-25
-
Website
https://www.laxmi.com 
Laxmi Organic Industries Limited, a specialty chemical manufacturer, provides acetyl and specialty intermediates in India. The company's acetyl intermediates include ethyl acetate, acetaldehyde, fuel-grade ethanol, and other proprietary solvents; and specialty intermediates comprise ketene and diketene derivatives, such as esters, acetic anhydride, amides, arylides, and other chemicals. Its products are used in pharmaceuticals, agrochemicals, dyes and pigments, inks and paints, coatings, printing, packaging, flavour and fragrance, adhesives, electronics, automotive, and other industrial applications. The company exports its products to approximately 43 countries. Laxmi Organic Industries Limited was incorporated in 1989 and is based in Mumbai, India.
